46 results on '"Amoreo, Carla Azzurra"'
Search Results
2. BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancer
3. TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients
4. Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
5. MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancer
6. HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome
7. Supplementary Material from BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer
8. Data from BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer
9. JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer
10. Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker
11. Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer
12. Deep sequencing and pathway-focused analysis revealed multigene oncodriver signatures predicting survival outcomes in advanced colorectal cancer
13. Liquid biopsy in mice bearing colorectal carcinoma xenografts: gateways regulating the levels of circulating tumor DNA (ctDNA) and miRNA (ctmiRNA)
14. HIPK2 Cooperates with KRAS Signaling and Associates with Colorectal Cancer Progression
15. FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma
16. Additional file 4 of Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
17. Additional file 5 of TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients
18. Additional file 6 of TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients
19. Additional file 3 of Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
20. Additional file 1 of TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients
21. Additional file 1 of Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
22. Additional file 4 of TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients
23. Additional file 2 of Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
24. Multicohort and cross‐platform validation of a prognostic Wnt signature in colorectal cancer
25. Assessment of HER2 Protein Overexpression and Gene Amplification in Renal Collecting Duct Carcinoma: Therapeutic Implication
26. FGFR2 fusion protein-driven mouse models of intrahepatic cholangiocarcinoma unveil a necessary role for Erk signaling
27. TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment
28. HIPK2 is a potential predictive marker of a favorable response for adjuvant chemotherapy in stage II colorectal cancer.
29. DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
30. Abstract 5: The histone acetyltransferase inhibitor CPTH6 impairs tumor angiogenesis acting on both endothelial and cancer cells
31. The clinical significance of PD-L1 in advanced gastric cancer is dependent onARID1Amutations and ATM expression
32. Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
33. CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells
34. DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
35. SIRT6 interacts with TRF2 and promotes its degradation in response to DNA damage
36. BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer
37. Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers
38. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance
39. Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis
40. Cancer stem cells: are they responsible for treatment failure?
41. SIRT6 interacts with TRF2 and promotes its degradation in response to DNA damage.
42. CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells
43. The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1A mutations and ATM expression.
44. The clinical significance of PD-L1 in advanced gastric cancer is dependent on ARID1Amutations and ATM expression
45. TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment
46. SIRT6 interacts with TRF2 and promotes its degradation in response to DNA damage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.